micro News and Research

RSS

Digested coconut oil able to attack the bacteria that cause tooth decay

Digested coconut oil is able to attack the bacteria that cause tooth decay. It is a natural antibiotic that could be incorporated into commercial dental care products, say scientists presenting their work at the Society for General Microbiology's Autumn Conference at the University of Warwick.

3 Sep 2012

GWSMHS professor to study correlation between genetics and susceptibility to drug abuse

Norman H. Lee, Ph.D., professor of pharmacology at the George Washington University School of Medicine and Health Sciences (SMHS), received a total of $405,001 in grant funding from the National Institute on Drug Abuse (NIDA) to continue to study the correlation between genetics and susceptibility to drug abuse.

30 Aug 2012

Blockade Medical's Barricade Coil System successfully treats patients with aneurysms

Blockade Medical announced today the first patients have been treated with the Barricade Coil System. Patients treated with the Barricade Coil System presented with diverse cerebral aneurysms.

27 Aug 2012

Proteonomix enters license agreement for new anti-tumor technology

Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.

23 Aug 2012

Portable Micro-Plasma Device may help repair skin after laser surgery

A National Cheng Kung University (NCKU) research team has designed a Portable Micro-Plasma Device (PMPD) that may be the ultimate solution to repairing the skin after laser surgery.

21 Aug 2012

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today successful results from two programs of work carried out by French partner VIVALIS (NYSE Euronext: VLS), confirming the ability of BioDiem’s Live Attenuated Influenza Virus (LAIV) to grow in VIVALIS’ proprietary EB66® cell line.

20 Aug 2012

Mercury exposure hypertension concerns ‘unfounded’

Mercury exposure is not associated with an increased risk for hypertension, US research shows.

13 Aug 2012

New class of polymers resistant to bacterial attachment

Using state-of-the-art technology scientists at The University of Nottingham have discovered a new class of polymers that are resistant to bacterial attachment. These new materials could lead to a significant reduction in hospital infections and medical device failures.

13 Aug 2012

Scientists discover new class of polymers that are resistant to bacterial attachment

13 Aug 2012

‘Green’ disinfectant shows promise against hospital-acquired infections

Research shows that the polyhexamethylene-guanidine hydrochloride-based disinfectant Akwaton effectively destroys Bacillus subtilis spores even at low concentrations.

8 Aug 2012

New research hopes to uncover mystery behind breast cancer metastasis

If detected early, most cases of breast cancer are curable. But if the tumour has metastasized - or spread to a site outside of the breast - cure rates decline. A team of researchers from Lawson Health Research Institute and Western University have received $449,733 from the Canadian Breast Cancer Foundation - Ontario Region to study a rare subpopulation of tumour cells called cancer stem cells (CSCs) in hopes of uncovering the mystery behind metastasis.

8 Aug 2012

BioDiem granted European patent for antimicrobial drug

Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.

7 Aug 2012

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

A significant discovery in the development of next-generation antibiotics has been made by Scottish biotechnology company Aquapharm.

6 Aug 2012

Researchers uncover 9 new genes associated with bone health

Researchers have uncovered 9 new genes associated with bone health. This collaborative study found clues to the cause of bone disorders such as osteoporosis, osteogenesis imperfecta, and high bone density syndromes by investigating the bone mineral content, strength and flexibility.

3 Aug 2012

Researchers describe new human tissue dendritic cell with cross-presenting function

Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source - providing a new potential target for vaccines for conditions such as cancer or Hepatitis B.

30 Jul 2012

Greatbatch second quarter 2012 sales increase 14% to $166.5 million

Greatbatch, Inc., today announced results for its second quarter ended June 29, 2012.

26 Jul 2012

NIH grants aim at creating 3-D tissue chips to help identify drug safety signals

Seventeen National Institutes of Health grants are aimed at creating 3-D chips with living cells and tissues that accurately model the structure and function of human organs such as the lung, liver and heart. Once developed, these tissue chips will be tested with compounds known to be safe or toxic in humans to help identify the most reliable drug safety signals - ultimately advancing research to help predict the safety of potential drugs in a faster, more cost-effective way.

25 Jul 2012

Microneedles can deliver drug formulations into the eye

Thanks to tiny microneedles, eye doctors may soon have a better way to treat diseases such as macular degeneration that affect tissues in the back of the eye. That could be important as the population ages and develops more eye-related illnesses - and as pharmaceutical companies develop new drugs that otherwise could only be administered by injecting into the eye with a hypodermic needle.

24 Jul 2012

FDA approves 152 antiretroviral drugs in association with PEPFAR to treat HIV/AIDS

Today, U.S. Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg announced the agency has approved or tentatively approved a total of 152 antiretroviral drugs in association with the President's Emergency Plan for AIDS Relief (PEPFAR) to treat those infected with HIV/AIDS in countries that lack the tools needed to fight the AIDS epidemic.

24 Jul 2012

Tiny microneedles to treat macular degeneration

23 Jul 2012

micro News and Research

Digested coconut oil able to attack the bacteria that cause tooth decay

GWSMHS professor to study correlation between genetics and susceptibility to drug abuse

Blockade Medical's Barricade Coil System successfully treats patients with aneurysms

Proteonomix enters license agreement for new anti-tumor technology

Portable Micro-Plasma Device may help repair skin after laser surgery

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Mercury exposure hypertension concerns ‘unfounded’

New class of polymers resistant to bacterial attachment

Scientists discover new class of polymers that are resistant to bacterial attachment

‘Green’ disinfectant shows promise against hospital-acquired infections

New research hopes to uncover mystery behind breast cancer metastasis

BioDiem granted European patent for antimicrobial drug

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

Researchers uncover 9 new genes associated with bone health

Researchers describe new human tissue dendritic cell with cross-presenting function

Greatbatch second quarter 2012 sales increase 14% to $166.5 million

NIH grants aim at creating 3-D tissue chips to help identify drug safety signals

Microneedles can deliver drug formulations into the eye

FDA approves 152 antiretroviral drugs in association with PEPFAR to treat HIV/AIDS

Tiny microneedles to treat macular degeneration

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News